Missale Tiruneh


Consulting (Strategy Management and HTA requirements), Immuno-oncology, Market Access, Oncology, Patient Journey, Patient Services, Patients, Pricing, Reimbursement & Market Access, Project Management, Rare Disease, Stakeholder Engagement & Promotion (Patients, Payers, Providers)

Having spent over seven years with the Canadian Agency for Drugs and Technologies in Health’s (CADTH) pCODR program (pan-Canadian Oncology Drug Review), Missale has a wide range of experience related to the assessment of cancer drugs in the Canadian landscape. This has included the oversight of more than 60 pCODR submissions in various tumor types through the HTA process and supporting the pCODR Expert Review Committee (pERC) during deliberations and writing of the pERC Initial and Final Recommendations.

Missale received both her undergraduate and master’s degrees from the University of Ottawa.

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.